Trade Summary

2 days ago, Simon Barry J., serving as Dir at ImmunityBio, Inc. (IBRX), sold 23,033 shares at $7.18 per share, for a total transaction value of $165,305.54. Following this transaction, Simon Barry J. now holds 2,827,788 shares of IBRX.

This sale represents a 0.81% decrease in Simon Barry J.'s stake in the company.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 5:29 PM ET, 1 day after the trade was made.

ImmunityBio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.